Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Patients' experience of colonoscopy in the English Bowel Cancer Screening Programme.

Ghanouni A, Plumb A, Hewitson P, Nickerson C, Rees CJ, von Wagner C.

Endoscopy. 2016 Mar;48(3):232-40. doi: 10.1055/s-0042-100613. Epub 2016 Feb 3.

PMID:
26841268
2.

Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme.

Lee TJ, Rutter MD, Blanks RG, Moss SM, Goddard AF, Chilton A, Nickerson C, McNally RJ, Patnick J, Rees CJ.

Gut. 2012 Jul;61(7):1050-7. doi: 10.1136/gutjnl-2011-300651. Epub 2011 Sep 22.

PMID:
21940723
3.

Patient experience of CT colonography and colonoscopy after fecal occult blood test in a national screening programme.

Plumb AA, Ghanouni A, Rees CJ, Hewitson P, Nickerson C, Wright S, Taylor SA, Halligan S, von Wagner C.

Eur Radiol. 2017 Mar;27(3):1052-1063. doi: 10.1007/s00330-016-4428-x. Epub 2016 Jun 10.

4.

The effect of high quality assurance measures in bowel cancer screening on patient satisfaction of colonoscopy.

Sarkar S, Athwal V, Sturgess RP, Lythgoe D, Bodger K.

J Gastrointestin Liver Dis. 2012 Sep;21(3):251-8.

5.

Use of CT colonography in the English Bowel Cancer Screening Programme.

Plumb AA, Halligan S, Nickerson C, Bassett P, Goddard AF, Taylor SA, Patnick J, Burling D.

Gut. 2014 Jun;63(6):964-73. doi: 10.1136/gutjnl-2013-304697. Epub 2013 Aug 16.

6.

Colonoscopic factors associated with adenoma detection in a national colorectal cancer screening program.

Lee TJ, Rees CJ, Blanks RG, Moss SM, Nickerson C, Wright KC, James PW, McNally RJ, Patnick J, Rutter MD.

Endoscopy. 2014 Mar;46(3):203-11. doi: 10.1055/s-0033-1358831. Epub 2014 Jan 28.

7.

Endoscopist characteristics that influence the quality of colonoscopy.

Jover R, Zapater P, Bujanda L, Hernández V, Cubiella J, Pellisé M, Ponce M, Ono A, Lanas A, Seoane A, Marín-Gabriel JC, Chaparro M, Cacho G, Herreros-de-Tejada A, Fernández-Díez S, Peris A, Nicolás-Pérez D, Murcia O, Castells A, Quintero E; COLONPREV Study Investigators.

Endoscopy. 2016 Mar;48(3):241-7. doi: 10.1055/s-0042-100185. Epub 2016 Feb 4.

PMID:
26845473
8.

Optimising faecal occult blood screening:retrospective analysis of NHS Bowel Cancer Screening data to improve the screening algorithm.

Geraghty J, Butler P, Seaman H, Snowball J, Sarkar S, Blanks R, Halloran S, Bodger K, Rees CJ.

Br J Cancer. 2014 Nov 25;111(11):2156-62. doi: 10.1038/bjc.2014.480. Epub 2014 Sep 16.

9.

Differences in screening vs non-screening colonoscopy: scope for improvement?

Ahmed S, Naumann DN, Karandikar S.

Colorectal Dis. 2016 Sep;18(9):903-9. doi: 10.1111/codi.13291.

PMID:
26850216
10.

Adenoma detection with cap-assisted colonoscopy versus regular colonoscopy: a randomised controlled trial.

de Wijkerslooth TR, Stoop EM, Bossuyt PM, Mathus-Vliegen EM, Dees J, Tytgat KM, van Leerdam ME, Fockens P, Kuipers EJ, Dekker E.

Gut. 2012 Oct;61(10):1426-34. doi: 10.1136/gutjnl-2011-301327. Epub 2011 Dec 20.

PMID:
22187070
11.

High yield of colorectal neoplasia detected by colonoscopy following a positive faecal occult blood test in the NHS Bowel Cancer Screening Programme.

Lee TJ, Clifford GM, Rajasekhar P, Rutter MD, Kometa S, Ritchie MC, Waddup G, Nylander D, McNally RJ, Rees CJ.

J Med Screen. 2011;18(2):82-6. doi: 10.1258/jms.2011.011032.

PMID:
21852700
12.

Ethnic variation in colorectal cancer risk following a positive faecal occult blood test in an English bowel cancer screening programme centre.

Padmanabhan H, Widlak M, Nevill A, McKaig B, Brookes M, Veitch A.

Eur J Gastroenterol Hepatol. 2015 Nov;27(11):1281-5. doi: 10.1097/MEG.0000000000000443.

PMID:
26267240
13.

Differences in detection rates of adenomas and serrated polyps in screening versus surveillance colonoscopies, based on the new hampshire colonoscopy registry.

Anderson JC, Butterly LF, Goodrich M, Robinson CM, Weiss JE.

Clin Gastroenterol Hepatol. 2013 Oct;11(10):1308-12. doi: 10.1016/j.cgh.2013.04.042. Epub 2013 May 6.

14.

Performance measures in three rounds of the English bowel cancer screening pilot.

Moss SM, Campbell C, Melia J, Coleman D, Smith S, Parker R, Ramsell P, Patnick J, Weller DP.

Gut. 2012 Jan;61(1):101-7. doi: 10.1136/gut.2010.236430. Epub 2011 May 10.

15.

Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).

Zorzi M, Senore C, Da Re F, Barca A, Bonelli LA, Cannizzaro R, Fasoli R, Di Furia L, Di Giulio E, Mantellini P, Naldoni C, Sassatelli R, Rex D, Hassan C, Zappa M; Equipe Working Group.

Gut. 2015 Sep;64(9):1389-96. doi: 10.1136/gutjnl-2014-307954. Epub 2014 Sep 16.

PMID:
25227521
16.

Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests.

Logan RF, Patnick J, Nickerson C, Coleman L, Rutter MD, von Wagner C; English Bowel Cancer Screening Evaluation Committee.

Gut. 2012 Oct;61(10):1439-46. Epub 2011 Dec 7.

17.

Water infusion versus air insufflation for colonoscopy.

Hafner S, Zolk K, Radaelli F, Otte J, Rabenstein T, Zolk O.

Cochrane Database Syst Rev. 2015 May 26;(5):CD009863. doi: 10.1002/14651858.CD009863.pub2. Review.

PMID:
26011829
18.

Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1.

19.

Non-neoplastic findings at colonoscopy after positive faecal occult blood testing: data from the English Bowel Cancer Screening Programme.

Bevan R, Lee TJ, Nickerson C, Rubin G, Rees CJ; NHS BCSP Evaluation Group.

J Med Screen. 2014 Jun;21(2):89-94. doi: 10.1177/0969141314528889. Epub 2014 Mar 18.

PMID:
24644029
20.

Performance of additional colonoscopies and yield of neoplasms within 3 years after screening colonoscopy: a historical cohort study.

Stock C, Hoffmeister M, Birkner B, Brenner H.

Endoscopy. 2013 Jul;45(7):537-46. doi: 10.1055/s-0032-1326485. Epub 2013 Jun 25.

PMID:
23801314

Supplemental Content

Support Center